Stock Price Forecast

March 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading ProPhase Labs Inc chart...

About the Company

prophase labs is a diversified natural health medical science company. for more information visit us at www.prophaselabs.com.

Exchange

NASDAQ

Website

prophaselabs.com

$74M

Total Revenue

53

Employees

$91M

Market Capitalization

-7.97

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $PRPH News

ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript

14h ago, source: InvestingChannel on MSN

March 15, 2024 ProPhase Labs, Inc. misses on earnings expectations. Reported EPS is $ EPS, expectations were $-0.27. PRPH isn't one of the 30 most popular stocks among hedge funds at the end of the ...

Down 34% and 57%, Wall Street Says These 2 Stocks Will Gain 230%

6d ago, source: 24/7 Wall St

In the volatile world of trading and investing, where fortunes can be made or lost in the blink of an eye, two companies ...

ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir

1mon ago, source: Business Insider

Commercialization of Equivir anticipated after second trial is completed in Q2, 2024 Garden City, NY, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation ...

ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART

27d ago, source: Business Insider

Garden City, NY, Feb. 20, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics and diagnostics company, today announced important developments in the ...

ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 29% Above Their Intrinsic Value Estimate

17d ago, source:

Key Insights The projected fair value for ProPhase Labs is US$3.46 based on Dividend Discount Model ProPhase Labs ...

Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)

27d ago, source: Yahoo Finance

a leading equity research firm with a focus on small capitalization public companies has released an Update Note on ProPhase Labs Inc. (NASDAQ: PRPH). The update note includes information on the ...

ProPhase Labs, Inc. (PRPH) Q4 2023 Earnings Call Transcript

3d ago, source: Seeking Alpha

On behalf of our team, we want to thank everyone for joining us today for ProPhase Labs' Fourth Quarter and Year-End 2023 Results. ProPhase is trading on the Nasdaq under the ticker symbol PRPH.

PRPH ProPhase Labs, Inc.

1mon ago, source: Seeking Alpha

ProPhase Labs, Inc. engages in the development and commercialization of novel drugs, dietary supplements, and compounds in the United States. The company operates in two segments, Diagnostic ...

ProPhase Labs Inc PRPH

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...